LES PROBIOTIQUES DANS LE TRAITEMENT DE L’ASTHME

Asthma; Immunity; Probiotics; probiotic agent; antiinflammatory activity; Article; asthma; chronic inflammation; drug safety; drug tolerability; human; immunoregulation; intestine flora; respiratory tract inflammation; adolescent; Adolescent; Gastrointestinal Microbiome; Humans

Abstract :

[en] Asthma is the most prevalent chronic inflammatory airway disease worldwide. The gut microbiota possesses an important link with the development of the immunity in youth and a dysregulation of the gut flora was implicated in the asthmatic disease emergence. Moreover, a dysregulation of the intestinal microbiota exists in asthmatic individual. Probiotics are micro-organisms that can regulate our microbiome conferring potential beneficial effects on health. Thereby, their use in asthma prevention and treatment is attractive and could lead to new therapeutic perspectives. Indeed, they are well tolerated and safe and possess anti-inflammatory and immunoregulatory properties. This article is intended to update the current state of knowledge regarding the use of probiotics in the context of asthma. © 2022 Revue Medicale de Liege. All rights reserved.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Moermans, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie

Graff, Sophie ; Université de Liège - ULiège > GIGA

Gerday, Sara ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie

Schleich, FLorence ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie

Guiot, Julien ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie

Njock, Makon-Sébastien ; Centre Hospitalier Universitaire de Liège - CHU > > Service de rhumatologie

Louis, Renaud ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie

Language :

French

Title :

LES PROBIOTIQUES DANS LE TRAITEMENT DE L’ASTHME

Alternative titles :

[en] PROBIOTICS IN ASTHMA TREATMENT

Publication date :

2022

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Revue Medicale de Liege

Volume :

Issue :

5-6

Pages :

285 - 288

Peer reviewed :

Editorial Reviewed verified by ORBi

Available on ORBi :

since 01 January 2023

Statistics

Number of views

135 (3 by ULiège)

Number of downloads

177 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Bettiol J, Radermecker M, Louis R. Clinique et cytologie sputaire de l’asthme intrinsèque. Rev Med Liege 2002;57:223-7.
Louis R, Schleich F, Corhay JL, Louis E. L’asthme: une maladie complexe mettant en jeu facteurs environnementaux et terrain génétique. Rev Med Liege 2012;67:286-91.
Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev 2015;28: PMID: 26324809.
Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;52: PMID: 24337046.
Hekking PPW, Wener RR, Amelink M, et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol 2015; 135:896-902.
Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990;142:863-71.
Benayoun L, Druilhe A, Dombret MC, et al. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167:1360-8.
Louis R, Corhay JL, Bury T. Radermecker MF. L’hyperréactivité bronchique non-spécifique: données épidémiologiques et signification clinique. Rev Med Liege 1993;48:213–9.
Wang Q, Li F, Liang B, et al. A metagenome-wide association study of gut microbiota in asthma in UK adults. BMC Microbiol 2018;18:144.
Nutrition division. Probiotics in food: health and nutritional properties and guidelines for evaluation: report of a joint FAO/ WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba: FAO/WHO; 2001. 56p.
Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess 2011;200:1-645.
Anatriello E, Cunha M, Nogueira J, et al. Oral feeding of Lactobacillus bulgaricus N45.10 inhibits the lung inflammation and airway remodeling in murine allergic asthma: Relevance to the Th1/Th2 cytokines and STAT6/T-bet. Cell Immunol 2019; 341:103928.
Halloran K, Underwood MA. Probiotic mechanisms of action. Early Hum Dev 2019;135:58-65.
Arrieta MC, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 2015;7:307ra152.
Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006;117:969-77.
Juan Z, Zhao-Ling S, Ming-Hua Z, et al. Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumininduced allergic airway inflammation in mice. Respirology 2017;22:898-904.
Niers LEM, Timmerman HM, Rijkers GT, et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005; 35:1481-9.
Durack J, Kimes NE, Lin DL, et al. Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation. Nat Commun 2018;9:707.
Lin J, Zhang Y, He C, Dai J. Probiotics supplementation in children with asthma: A systematic review and meta-analysis. J Paediatr Child Health 2018;54:953-961.
Ahanchian H, Jafari SA, Ansari E, et al. A multi-strain Synbiotic may reduce viral respiratory infections in asthmatic children: a randomized controlled trial. Electron physician 2016;8:2833-2839.
Chen YS, Lin YL, Jan RL, et al. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 2010;45:1111-20.
Huang CF, Chie WC, Wang IJ. Efficacy of Lactobacillus administration in school-age children with asthma: A randomized, placebo-controlled trial. Nutrients 2018;10:1678.
Cabana MD. No consistent evidence to date that prenatal or postnatal probiotic supplementation prevents childhood asthma and wheeze. Evid Based Med 2014;19:144.
Van De Pol MA, Lutter R, Smids BS, et al. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 2011;66:39-47.
Liu J, Chen FH, Qiu SQ, et al. Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients. Am J Transl Res 2016;8:5256-5270.
Jamalkandi SA, Ahmadi A, Ahrari I, et al. Oral and nasal probiotic administration for the prevention and alleviation of allergic diseases, asthma and chronic obstructive pulmonary disease. Nutr Res Rev 2021;34:1-16.